153
Participants
Start Date
October 1, 2022
Primary Completion Date
October 27, 2023
Study Completion Date
October 27, 2023
Difamilast
Off-white ointment containing active ingredient, petrolatum and other ingredients
Placebo
Matching Difamilast (Study drug) ointment without active ingradient
Peak Research, LLC, Upper Saint Clair
DermAssociates, LLC, Rockville
Dermatology Consulting Services, PLLC, High Point
Accel Research - Edgewater Clinical Research Unit, Edgewater
Accel Research - Ormond Clinical Research Unit, Ormond Beach
Nona Pediatrics, Orlando
Tory Sullivan, MD PA, North Miami Beach
TrueBlue Clinical Research, Brandon
Olympian Clinical Research, St. Petersburg
AllerVie Health, Birmingham
International Clinical Research - Tennessee LLC, Murfreesboro
DS Research, Louisville
Bexley Dermatology Research, Bexley
Remington-Davis, Inc., Columbus
Optima Research, Boardman
The Indiana Clinical Trials Center, Plainfield
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
South Bend Clinic, South Bend
DS Research, Clarksville
Oakland Hills Dermatology, PC, Auburn Hills
Minnesota Clinical Study Center, New Brighton
Arlington Dermatology, Rolling Meadows
Clinical Trials Management, LLC, Metairie
Avant Research Associates, LLC, Crowley
NEA Baptist Clinic-Dermatology, Jonesboro
North Texas Center for Clinical Research, Frisco
Arlington Research Center, Inc., Arlington
Center for Clinical Studies, Ltd, LLP, Houston
Houston Center for Clinical Research, Sugar Land
IMMUNOe Research Centers, Centennial
Elite Clinical Studies, LLC, Phoenix
Dermatology Research Associates, Los Angeles
Clinical Trials Research Institute, Thousand Oaks
Shahram Jacobs, MD Inc., Sherman Oaks
First OC Dermatology, Fountain Valley
Antelope Valley Clinical Trials, Lancaster
Center for Dermatology Clinical Research, Inc., Fremont
Premier Clinical Research, LLC, Spokane
Metro Boston Clinical Partners, Brighton
Lead Sponsor
Acrotech Biopharma Inc.
INDUSTRY